Corrigendum to “Potent antimalarial 4-pyridones with improved physico-chemical properties” [Bioorg. Med. Chem. Lett. 21 (2011) 5214–5218]
José M. Bueno(GlaxoSmithKline (United Kingdom)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), José M. Fiandor(GlaxoSmithKline (United Kingdom)), Jesús Chicharro(GlaxoSmithKline (United Kingdom)), Rubén M. Gómez(GlaxoSmithKline (Spain)), María Fraile(GlaxoSmithKline (Spain)), María C. García(GlaxoSmithKline (Spain)), Adolfo García(GlaxoSmithKline (Spain)), Santiago Ferrer(GlaxoSmithKline (Spain)), Jaume Vidal(GlaxoSmithKline (Spain)), Pilar Manzano(GlaxoSmithKline (Spain)), José Luís Lavandera(GlaxoSmithKline (Spain)), Esperanza Herreros(GlaxoSmithKline (Spain)), Margarita Puente(GlaxoSmithKline (Spain)), Milagros Lorenzo(GlaxoSmithKline (Spain))
Cited by 2
Related Papers
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes
|Antimicrobial Agents and Chemotherapy|2009|189
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|PLoS ONE|2008|164
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
|Journal of Medicinal Chemistry|2008|139
Transmission of Pneumocystis carinii Disease from Immunocompetent Contacts of Infected Hosts to Susceptible Hosts
|European Journal of Clinical Microbiology & Infectious Diseases|2000|134
Anticoagulants Interfere with PCR Used To Diagnose Invasive Aspergillosis
|Journal of Clinical Microbiology|2002|122